ExoS and ExoT ADP ribosyltransferase activities mediate pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1884-1895

  Sun, Yan ^a   Karmakar, Mausita ^a   Taylor, Patricia R ^a   Rietsch, Arne ^a   Pearlman, Eric ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; EXOS GENE; EXOT GENE; GENE; GENE EXPRESSION; GENE FUNCTION; KERATITIS; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADP RIBOSE TRANSFERASES; ANIMALS; APOPTOSIS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BACTERIAL TOXINS; CELLS, CULTURED; CORNEA; GLUCOSYLTRANSFERASES; GTPASE-ACTIVATING PROTEINS; KERATITIS; MICE; MICE, INBRED C57BL; NEUTROPHILS; PSEUDOMONAS AERUGINOSA;

EID: 84863136696     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102148     Document Type: Article

References (63)

1. Al-Hazzaa, S. A., and K. F. Tabbara. 1988. Bacterial keratitis after penetrating keratoplasty. Ophthalmology 95: 1504-1508.
2. Bharathi, M. J., R. Ramakrishnan, R. Meenakshi, C. S. Kumar, S. Padmavathy, and S. Mittal. 2007. Ulcerative keratitis associated with contact lens wear. Indian J. Ophthalmol. 55: 64-67. (Pubitemid 46065938)
3. Green, M., A. Apel, and F. Stapleton. 2008. Risk factors and causative organisms in microbial keratitis. Cornea 27: 22-27.
4. Schaefer, F., O. Bruttin, L. Zografos, and Y. Guex-Crosier. 2001. Bacterial keratitis: a prospective clinical and microbiological study. Br. J. Ophthalmol. 85: 842-847. (Pubitemid 32662086)
5. Willcox, M. D. 2007. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom. Vis. Sci. 84: 273-278. (Pubitemid 46624851)
6. Shah, A., A. Sachdev, D. Coggon, and P. Hossain. 2011. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br. J. Ophthalmol. 95: 762-767.
7. Huang, X., W. Du, S. A. McClellan, R. P. Barrett, and L. D. Hazlett. 2006. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 47: 4910-4916. (Pubitemid 46586392)
8. Rudner, X. L., K. A. Kernacki, R. P. Barrett, and L. D. Hazlett. 2000. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J. Immunol. 164: 6576-6582. (Pubitemid 30408844)
9. Sun, Y., M. Karmakar, S. Roy, R. T. Ramadan, S. R. Williams, S. Howell, C. L. Shive, Y. Han, C. M. Stopford, A. Rietsch, and E. Pearlman. 2010. TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways. J. Immunol. 185: 4272-4283.
10. Zaidi, T., M. Bajmoczi, T. Zaidi, D. E. Golan, and G. B. Pier. 2008. Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 49: 1000-1009.
11. Roy, S., Y. Sun, and E. Pearlman. 2011. Interferon-gamma-induced MD-2 protein expression and lipopolysaccharide (LPS) responsiveness in corneal epithelial cells is mediated by Janus tyrosine kinase-2 activation and direct binding of STAT1 protein to the MD-2 promoter. J. Biol. Chem. 286: 23753-23762.
12. Power, M. R., J. S. Marshall, M. Yamamoto, S. Akira, and T. J. Lin. 2006. The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice. Clin. Exp. Immunol. 146: 323-329. (Pubitemid 44581348)
13. Power, M. R., Y. Peng, E. Maydanski, J. S. Marshall, and T. J. Lin. 2004. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J. Biol. Chem. 279: 49315-49322. (Pubitemid 39625818)
14. Skerrett, S. J., C. B. Wilson, H. D. Liggitt, and A. M. Hajjar. 2007. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L312-L322. (Pubitemid 46103456)
15. Koh, A. Y., G. P. Priebe, C. Ray, N. Van Rooijen, and G. B. Pier. 2009. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect. Immun. 77: 5300-5310.
16. Hauser, A. R. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7: 654-665.
17. Galán, J. E., and H. Wolf-Watz. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444: 567-573. (Pubitemid 44864429)
18. Sato, H., and D. W. Frank. 2004. ExoU is a potent intracellular phospholipase. Mol. Microbiol. 53: 1279-1290. (Pubitemid 39209104)
19. Barbieri, J. T., and J. Sun. 2004. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152: 79-92. (Pubitemid 44404359)
20. Kazmierczak, B. I., K. Mostov, and J. N. Engel. 2004. Epithelial cell polarity alters Rho-GTPase responses to Pseudomonas aeruginosa. Mol. Biol. Cell 15: 411-419. (Pubitemid 38146461)
21. Krall, R., J. Sun, K. J. Pederson, and J. T. Barbieri. 2002. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect. Immun. 70: 360-367. (Pubitemid 34028636)
22. Engel, J., and P. Balachandran. 2009. Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 12: 61-66.
23. Feltman, H., G. Schulert, S. Khan, M. Jain, L. Peterson, and A. R. Hauser. 2001. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147: 2659-2669. (Pubitemid 32976307)
24. Cowell, B. A., B. A. Weissman, K. K. Yeung, L. Johnson, S. Ho, R. Van, D. Bruckner, B. Mondino, and S. M. Fleiszig. 2003. Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea 22: 131-134. (Pubitemid 36701914)
25. Tam, C., S. E. Lewis, W. Y. Li, E. Lee, D. J. Evans, and S. M. Fleiszig. 2007. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. Exp. Eye Res. 85: 799-805. (Pubitemid 350166366)
26. Lee, E. J., T. N. Truong, M. N. Mendoza, and S. M. Fleiszig. 2003. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics. Curr. Eye Res. 27: 289-299. (Pubitemid 37445266)
27. Lee, E. J., D. J. Evans, and S. M. Fleiszig. 2003. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Invest. Ophthalmol. Vis. Sci. 44: 5220-5227. (Pubitemid 37475392)
28. Lee, E. J., B. A. Cowell, D. J. Evans, and S. M. Fleiszig. 2003. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest. Ophthalmol. Vis. Sci. 44: 3892-3898. (Pubitemid 37047960)
29. Diaz, M. H., and A. R. Hauser. 2010. Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia. Infect. Immun. 78: 1447-1456.
30. Vance, R. E., A. Rietsch, and J. J. Mekalanos. 2005. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect. Immun. 73: 1706-1713. (Pubitemid 40470759)
31. Diaz, M. H., C. M. Shaver, J. D. King, S. Musunuri, J. A. Kazzaz, and A. R. Hauser. 2008. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 76: 4414-4421.
32. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
33. Köhler, T., C. van Delden, L. K. Curty, M. M. Hamzehpour, and J. C. Pechere. 2001. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183: 5213-5222. (Pubitemid 32802590)
34. Rietsch, A., M. C. Wolfgang, and J. J. Mekalanos. 2004. Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa. Infect. Immun. 72: 1383-1390. (Pubitemid 38263759)
35. Cisz, M., P. C. Lee, and A. Rietsch. 2008. ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa. J. Bacteriol. 190: 2726-2738. (Pubitemid 351508173)
36. Sun, J., and J. T. Barbieri. 2003. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. Chem. 278: 32794-32800. (Pubitemid 37055720)
37. Leal, S. M., Jr., S. Cowden, Y. C. Hsia, M. A. Ghannoum, M. Momany, and E. Pearlman. 2010. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog. 6: e1000976.
38. Burnett, S. H., E. J. Kershen, J. Zhang, L. Zeng, S. C. Straley, A. M. Kaplan, and D. A. Cohen. 2004. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 75: 612-623. (Pubitemid 38405652)
39. Chinnery, H. R., E. C. Carlson, Y. Sun, M. Lin, S. H. Burnett, V. L. Perez, P. G. McMenamin, and E. Pearlman. 2009. Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation. J. Immunol. 182: 2738-2744.
40. Burnett, S. H., B. J. Beus, R. Avdiushko, J. Qualls, A. M. Kaplan, and D. A. Cohen. 2006. Development of peritoneal adhesions in macrophage depleted mice. J. Surg. Res. 131: 296-301.
41. Sun, Y., T. Fox, G. Adhikary, M. Kester, and E. Pearlman. 2008. Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide. J. Leukoc. Biol. 83: 1512-1521. (Pubitemid 351960333)
42. Lin, M., E. Carlson, E. Diaconu, and E. Pearlman. 2007. CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis. J. Leukoc. Biol. 81: 786-792. (Pubitemid 46393556)
43. Dacheux, D., I. Attree, and B. Toussaint. 2001. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect. Immun. 69: 538-542. (Pubitemid 32038355)
44. Alaoui-El-Azher, M., J. Jia, W. Lian, and S. Jin. 2006. ExoS of Pseudomonas aeruginosa induces apoptosis through a Fas receptor/caspase 8-independent pathway in HeLa cells. Cell. Microbiol. 8: 326-338. (Pubitemid 43356054)
45. Shafikhani, S. H., C. Morales, and J. Engel. 2008. The Pseudomonas aeruginosa type III secreted toxin ExoT is necessary and sufficient to induce apoptosis in epithelial cells. Cell. Microbiol. 10: 994-1007. (Pubitemid 351386952)
46. Gipson, I. K. 2007. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 48: 4391-4398. (Pubitemid 351260950)
47. McDermott, A. M. 2009. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 41: 60-75.
48. Alarcon, I., C. Tam, J. J. Mun, J. LeDue, D. J. Evans, and S. M. Fleiszig. 2011. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest. Ophthalmol. Vis. Sci. 52: 1368-1377.
49. Szczotka-Flynn, L. B., Y. Imamura, J. Chandra, C. Yu, P. K. Mukherjee, E. Pearlman, and M. A. Ghannoum. 2009. Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions. Cornea 28: 918-926.
50. Tam, C., J. J. Mun, D. J. Evans, and S. M. Fleiszig. 2010. The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis. Invest. Ophthalmol. Vis. Sci. 51: 3100-3106.
51. Angus, A. A., A. A. Lee, D. K. Augustin, E. J. Lee, D. J. Evans, and S. M. Fleiszig. 2008. Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect. Immun. 76: 1992-2001. (Pubitemid 351656131)
52. Angus, A. A., D. J. Evans, J. T. Barbieri, and S. M. Fleiszig. 2010. The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells. Infect. Immun. 78: 4500-4510.
53. Jansson, A. L., L. Yasmin, P. Warne, J. Downward, R. H. Palmer, and B. Hallberg. 2006. Exoenzyme S of Pseudomonas aeruginosa is not able to induce apoptosis when cells express activated proteins, such as Ras or protein kinase B/Akt. Cell. Microbiol. 8: 815-822.
54. Kaufman, M. R., J. Jia, L. Zeng, U. Ha, M. Chow, and S. Jin. 2000. Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of exoS. Microbiology 146: 2531-2541.
55. Lee, V. T., R. S. Smith, B. Tümmler, and S. Lory. 2005. Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection. Infect. Immun. 73: 1695-1705. (Pubitemid 40470758)
56. Alarcon, I., L. Kwan, C. Yu, D. J. Evans, and S. M. Fleiszig. 2009. Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa. Infect. Immun. 77: 3264-3271.
57. Finck-Barbançon, V., J. Goranson, L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M. Fleiszig, C. Wu, L. Mende-Mueller, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25: 547-557. (Pubitemid 27373583)
58. Shaver, C. M., and A. R. Hauser. 2004. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect. Immun. 72: 6969-6977. (Pubitemid 39552365)
59. Shaver, C. M., and A. R. Hauser. 2006. Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology 152: 143-152. (Pubitemid 43092402)
60. Garrity-Ryan, L., S. Shafikhani, P. Balachandran, L. Nguyen, J. Oza, T. Jakobsen, J. Sargent, X. Fang, S. Cordwell, M. A. Matthay, and J. N. Engel. 2004. The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities. Infect. Immun. 72: 546-558. (Pubitemid 38018216)
61. Khan, S., N. Cole, E. B. Hume, L. Garthwaite, T. C. Conibear, D. H. Miles, Y. Aliwaga, M. B. Krockenberger, and M. D. Willcox. 2007. The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection. J. Leukoc. Biol. 81: 315-318. (Pubitemid 46021281)
62. Bleves, S., C. Soscia, P. Nogueira-Orlandi, A. Lazdunski, and A. Filloux. 2005. Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J. Bacteriol. 187: 3898-3902. (Pubitemid 40705600)
63. Rietsch, A., I. Vallet-Gely, S. L. Dove, and J. J. Mekalanos. 2005. ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 102: 8006-8011. (Pubitemid 40781053)